Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: Results of a randomized, double-blind, placebo-controlled trial

Current Medical Research and Opinion

Volumn 27, Issue 12, 2011, Pages 2361-2372

  Frakes, E P ^a   Risser, R C ^a   Ball, T D ^b   Hochberg, M C ^c   Wohlreich, M M ^a  

^a ELI LILLY AND COMPANY   (United States)

^b i3 Data Services   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Duloxetine; Efficacy; Function; NSAIDs; Osteoarthritis; Pain; Safety

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; DULOXETINE; IBUPROFEN; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARACETAMOL;

ADULT; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA;

ADMINISTRATION, ORAL; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KNEE; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MANAGEMENT; THIOPHENES; TIME FACTORS;

EID: 81855225268     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.633502     Document Type: Article

References (24)

1. Medical management of adults with osteoarthritis. Southfield (MI): Michigan Quality Improvement Consortium, 2009
2. Osteoarthritis. The care and management of osteoarthritis in adults. London: National Collaborating Centre for Chronic Conditions. National Institute for Health and Clinical Excellence (NICE), 2008
3. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
4. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15
5. Choosing Non-Opioid Analgesics for Osteoarthritis: Clinician Guide. Rockville (MD): Agency for Healthcare Research and Quality, 2007
6. American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 2008; 59:1058
7. Bjordal JM. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007;11:125-38
8. Chappell AS, Ossanna MJ, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009;146:253-60
9. Chappell AS, Desaiah D, Liu-Seifert H, et al. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2011;11:33-41
10. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49
11. Schelman JM, Hindley CE. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events. Clin Ther 2010;32:667-77
12. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40
13. Guy W. Assessment Manual for Psychopharmacology, Revised. Rockville (MD): Department of Health, Education, and Welfare, 1976
14. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38
15. Emkey R, Rosenthal N, Wu SC, et al. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. J Rheumatol 2004; 31:150-6
16. Westfall PH, Krishnan A. Optimally weighted, fixed sequence and gatekeeper multiple testing procedures. J Stat Plann Inference 2001;99:25-40
17. Turk DC, Dworkin RH, McDermott MP, et al. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain 2008; 139:485-93
18. Pham T, Van Der Heijde D, Lassere M, et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol 2003;30:1648-54
19. Osiri M, Suarez-Almazor ME, Wells GA, et al. Number needed to treat (NNT): implication in rheumatology clinical practice. Ann Rheum Dis 2003; 62:316-21
20. Mease PJ, Hanna S, Frakes EP, et al. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol 2011;38:1546-51
21. Hochman JR, French MR, Bermingham SL, et al. The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken) 2010;62:1019-23
22. Hochman JR, Gagliese L, Davis AM, et al. Neuropathic pain symptoms in a community knee OA cohort. Osteoarthritis Cartilage 2011;19:647-54
23. Skljarevski V, Ossanna M, Liu-Seifert H, et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009;16:1041-8
24. Ausiello JC, Stafford RS. Trends in medication use for osteoarthritis treatment. J Rheumatol 2002;29:999-1005